$FOLD AMICUS THERAPEUTICS, INC. Insiders

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of current and past insiders in AMICUS THERAPEUTICS, INC.. Find out how many shares they currently own, their value and whether they buy or sell their shares.

AMICUS THERAPEUTICS, INC. Insiders

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Andrews Kurt J.SVP, Human Resources40,469243,623shares bought: 44,737 / shares sold: -10,000 STRONG BUYJul 05 2018
Baird William D IIIChief Financial Officer127,622768,284shares bought: 149,475 / shares sold: -92,054 BUYOct 17 2018
Baldry MarkVP Global Marketing25,000150,500Jun 04 2015
BARER SOL JDirector00Jun 13 2016
BARER SOL JDirector45,000270,900Jun 16 2014
BARER SOL JDirector20,000120,400Jun 14 2011
BARKAS ALEXANDER EDirector33,608202,320Jun 14 2011
BARRETT M JAMESDirector4,584,31127,597,552Jun 16 2014
BARRIS PETER J10% Owner851,1835,124,122Jul 27 2007
BARRIS PETER J10% Owner4,584,31127,597,552Mar 09 2012
Barth JayChief Medical Officer191,9541,155,563shares bought: 862,546 / shares sold: -772,337 BUYSep 02 20209 months ago
Bleil Lynn DorseyDirector21,705130,664shares bought: 21,705 / shares sold: 0 STRONG BUYJun 08 202011 months ago
Bloch Stephen MDirector61,700371,434Feb 12 2009
Bloch Stephen MDirector68,804414,200Aug 19 2008
Bloch Stephen MDirector66,936402,955Sep 11 2008
Boudes Pol FChief Medical Officer00Feb 17 2012
Boudes Pol FChief Medical Officer00Jun 06 2012
Campbell Bradley LChief Operating Officer422,5362,543,667shares bought: 825,667 / shares sold: -542,620 BUYMay 05 202112 days ago
Campbell Bradley LChief Operating Officer200,0001,204,000Jan 30 2015
Canaan Equity Partners III LLC10% Owner2,050,79012,345,756Jun 07 2007
Castelli JeffSVP, Program Management25,000150,500Jun 24 2015
CHL Medical Partners II, L.P.10% Owner2,108,55412,693,495Jun 07 2007
CHL Medical Partners II Side Fund, L.P.10% Owner2,108,55512,693,501Jun 07 2007
Clark David MichaelChief People Officer174,3891,049,822shares bought: 208,730 / shares sold: -28,992 STRONG BUYApr 08 20211 month ago
Crowley John FChairman & CEO884,7305,326,075shares bought: 2,647,836 / shares sold: -2,036,042 BUYMay 05 202112 days ago
Crowley John FChairman & CEO109,083656,680Jan 30 2015
David AllsopSVP International50,000301,000Apr 28 2015
Dentzer James EChief Financial Officer32,075193,092Oct 01 2009
Dentzer James EChief Financial Officer35,375212,958Jul 02 2008
Dilone EnriqueSVP, Technical Operations30,688184,742Jun 23 2015
Dilone EnriqueVP, Technical Operations50,000301,000Jan 30 2015
Do HungChief Science Officer448,6172,700,674shares bought: 655,714 / shares sold: -858,003 SELLApr 08 20211 month ago
Doshi DipalSVP Strategy & Bus Dev1,70610,270Jul 09 2015
ESSNER ROBERTDirector21,000126,420shares bought: 21,000 / shares sold: 0 STRONG BUYJun 08 202011 months ago
ESSNER ROBERTDirector00Jun 16 2014
FHM IV LP10% Owner497,8902,997,298Feb 06 2008
FHM IV LP10% Owner920,6645,542,397Mar 10 2008
Garden State Life Sciences Venture Fund L P10% Owner1,419,7628,546,967Jun 07 2007
Gershkowitz JayneSVP, Chief Patient Advocate5,69334,272Jul 01 2015
Gilmore GeoffreySVP & General Counsel00Mar 13 2012
GLAXOSMITHKLINE PLC10% Owner11,315,82568,121,267Nov 22 2013
GLAXOSMITHKLINE PLC10% Owner00Oct 28 2014
HAYDEN DONALD J JRDirector8,89553,548shares bought: 11,976 / shares sold: 0 STRONG BUYJun 11 2018
HAYDEN DONALD J JRDirector00Jun 20 2011
HAYDEN DONALD J JRDirector00Jun 16 2014
John McAdam MVP, Finance & Accounting00Jun 17 2010
Kelly Michael AaronDirector8,83753,199shares bought: 8,837 / shares sold: 0 BUYDec 02 20206 months ago
Kirk JohnVP, Regulatory Affairs5,68734,236Jun 03 2015
Kirk JohnVP, Regulatory Affairs50,000301,000Jan 30 2015
KRAMLICH C RICHARD10% Owner851,1835,124,122Jul 27 2007
KRAMLICH C RICHARD10% Owner4,584,31127,597,552Mar 09 2012
Licholai Gregory PVP, Medical Affairs152915Feb 05 2009
Lockhart David JChief Scientific Officer00Feb 17 2012
Lockhart David JChief Scientific Officer00Jun 20 2013
LOVE TED WDirector131,000788,620shares bought: 14,750 / shares sold: 0 STRONG BUYJun 08 202011 months ago
LOVE TED WDirector142,000854,840Dec 15 2014
Macaluso Peter MVP & Corporate Counsel00Jun 20 2013
MCGLYNN MARGARET GDirector37,919228,272shares bought: 71,000 / shares sold: -50,000 BUYMay 05 202112 days ago
MCGLYNN MARGARET GDirector00Jun 14 2011
MCGLYNN MARGARET GDirector00Jun 16 2014
NEFF P SHERRILLDirector1,419,7628,546,967Jun 17 2010
NEFF P SHERRILLDirector00Jun 13 2008
NEW ENTERPRISE ASSOCIATES 11 LP10% Owner4,584,31127,597,552Mar 09 2012
NEWHALL CHARLES W III10% Owner851,1835,124,122Jul 27 2007
NEWHALL CHARLES W III10% Owner4,584,31127,597,552Mar 09 2012
Palling DavidSr VP, Technical Operations34,040204,921Jun 30 2009
Patterson Matthew RActing CEO & President106,547641,413Apr 19 2011
Peist KennethVP, Legal & IP18,874113,621Jan 06 2016
Peist KennethVP, Legal & IP50,000301,000Jan 30 2015
PERCEPTIVE ADVISORS LLC10% Owner20,694,424124,580,432shares bought: 3,147,477 / shares sold: -1,100,000 STRONG BUYOct 05 2018
PERCEPTIVE ADVISORS LLC10% Owner14,439,44486,925,453Nov 19 2014
PERRY MARK W10% Owner851,1835,124,122Jul 27 2007
PERRY MARK W10% Owner4,584,31127,597,552Mar 09 2012
PROSPECT VENTURE PARTNERS II LP10% Owner33,608202,320Jun 06 2007
Prout Samantha WhitemanPrincipal Accounting Officer88,875535,028shares bought: 99,102 / shares sold: -16,610 STRONG BUYApr 19 202128 days ago
QUAKER BIO VENTURES LP10% Owner1,419,7628,546,967Jun 07 2007
Quimi DaphneChief Financial Officer290,6291,749,587shares bought: 341,979 / shares sold: -135,085 STRONG BUYApr 08 20211 month ago
Quimi DaphneVP Finance and Controller50,000301,000Jan 30 2015
RAAB MICHAELDirector21,000126,420shares bought: 46,000 / shares sold: -25,000 STRONG BUYJun 08 202011 months ago
RAAB MICHAELDirector00Jun 11 2008
RAAB MICHAELDirector00Jun 14 2011
RAAB MICHAELDirector00Jun 16 2014
Redmile Group, LLC10% Owner12,956,44677,997,805shares bought: 66,300 / shares sold: 0 BUYJun 13 2016
Rosenberg EllenChief Legal Officer241,2061,452,060shares bought: 350,205 / shares sold: -141,165 STRONG BUYApr 08 20211 month ago
SBLENDORIO GLENNDirector33,933204,277shares bought: 24,081 / shares sold: 0 STRONG BUYJun 08 202011 months ago
SBLENDORIO GLENNDirector12,93377,857Jun 14 2011
SBLENDORIO GLENNDirector11,93371,837Aug 29 2014
Schaeffer Orlov S NicoleSVP, HR & Leadership Devt12,58275,744Feb 17 2012
Shenker AndrewVP, Clinical Research00Feb 05 2009
Topper James NDirector13,12879,031Jun 14 2011
Topper James NDirector920,6645,542,397Mar 10 2008
Topper James NDirector149,134897,787Jun 29 2007
Topper James NDirector00Jun 12 2008
Topper James NDirector00Jun 16 2014
Valenzano KenSVP, Pharmacology & Biology27,687166,676Jul 15 2015
Valenzano KenVP, Pharmacology & Biology50,000301,000Jan 30 2015
Weinhoff Gregory MDirector2,108,55512,693,501Jun 07 2007
Weinhoff Gregory MDirector129,943782,257Aug 18 2008
WHEELER CRAIG ADirector21,000126,420shares bought: 24,081 / shares sold: 0 STRONG BUYJun 08 202011 months ago
WHITMAN BURKE WDirector45,967276,721shares bought: 35,467 / shares sold: 0 STRONG BUYMay 05 202112 days ago
Winkler Robert EVP, Clin Research & Operations00Feb 17 2012
Winkler Robert EVP, Clin Research & Operations00Jun 06 2012
Winterbottom JoanSVP, Human Resources1,66510,023Jun 20 2013
Yu JulieVP Clinical Ops & Data Mgmt00Jun 16 2015